Reliance Multi Cap Fund

This product is suitable for investors who are seeking*

· Long term capital growth.· investment in equity and equity related securities.

*Investors should consult their financial advisors if in doubt about whether the product is suitable for them. Investors understand that their principal will be at Moderately High risk

Invest in a fund that aimsto pick up the right opportunities

Invest withReliance Multi Cap Fund

• Attempts to combine stability of large caps with growth potential of mid-caps

• Unique blend of companies with strong fundamentals and scalable business models, along with exposure to emerging themes

RelianceMulti Cap Fund

(formerly, Reliance Equity Opportunities Fund)(Multi Cap Fund - An open ended equity scheme investing across

large cap, mid cap, small cap stocks)

Contact your financial advisor for further detailsCall 1860 266 0111* | SMS ‘INVEST’ to 561617 I www.reliancemutual.com

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

Sponsors: Reliance Capital

Nippon Life Insurance Company

*Local call charges apply. | SMS charges apply.

Reliance Multi Cap Fund

TOP 10 STOCKS WEIGHTAGE (%)

State Bank of India 9.81

Axis Bank Limited 6.69

The Indian Hotels Company Limited 5.54

ICICI Bank Limited 4.98

Aditya Birla Fashion and Retail Limited 3.89

Divi's Laboratories Limited 3.74

Bharat Petroleum Corporation Limited 3.50

HDFC Bank Limited 3.32

Larsen & Toubro Limited 3.31

Honeywell Automation India Limited 3.19Note: For complete portfolio, please refer website www.reliancemutual.com. Current Portfolio Allocation is based on the prevailing market conditions and is subject to changes depending on the fund manager’s view of the equity markets. Sector(s) / Stock(s) / Issuer(s) mentioned above are for the purpose of disclosure of the portfolio of the Scheme(s) and should not be construed as recommendation.

TOP 5 SECTORS

Banks 28.3%

IndustrialCapital Goods 13.2%

Hotels, Resorts And Other Recreational

Activities9.2%

Retailing 7.6%

ConstructionProject 5.9%

2

SCHEME DETAILS

PORTFOLIO DETAILS

Inception Date

Scheme Type

Fund Manager

Fund Size

Benchmark

Entry Load

Exit Load

• 28th March 2005

• Month end AUM: Rs. 10464.06 crs (Mar 2019)

• Multi Cap Fund- An open ended equity scheme investing across large cap, mid cap, small cap stocks

• S&P BSE 500 TRI

• Sailesh Raj Bhan

• Nil

• 1% if redeemed or switched out on or before completion of 1 year from the date of allotment of units.

• Nil if redeemed or switched out after the completion of 1 year from the date of allotment of units.

CURRENT INVESTMENT PHILOSOPHY

It is a multi-cap, trend based fund with the flexibility to be overweight in a particular sector or market caps depending on the potential & opportunities as they arise. Investment in large caps may help to capture market movements & ensures liquidity in volatile times while exposure to niche themes (pri-marily mid/small cap companies) having scalable business models offers alpha creation possibilities. The investment in the emerging businesses can be further categorized as:

� Quality Mid cap plays with a track record and scalable business models

� Emerging or niche themes with sustainable competitive advantages

� Deep Value Component –> Deep Value Stocks - Currently mispriced by markets due to nonfunda-mental reasons

WHY INVEST

� The fund invests in combination of market leaders, sustainable alpha creators and emerging themes.

� The portfolio is well positioned to benefit from domestic revival through allocations in themes like:• Urban Discretionary – Auto, Retail• Short Cycle Capex - Industrial Capital Goods, Industrial Products• Niche Themes - Entertainment, Insurance, Hotels/Resorts

Lumpsum Performance

Note: As TRI data is not available since inception of the scheme, benchmark performance is calculated using composite CAGR of S&P BSE 500 PRI values from 28/03/2005 to 29/06/2007 and TRI values since 29/06/2007. The performance details provided herein are of Growth Plan (Regular Plan). Please Refer Page 3 for detailed Scheme Performance.

The performance details provided herein are of Growth Plan (Regular Plan). Please refer Page 4 for detailed SIP Performance

Dividend HistoryRecord Date Rate (Re/ Unit) Cum Dividend NAV *EX Dividend NAV

22-Mar-19 2.43 30.4022 27.652223-Mar-18 4.75 32.8016 28.051617-Mar-17 3.00 31.6909 28.690923-Mar-16 2.75 29.1413 26.391320-Mar-15 4.00 37.7197 33.719714-Mar-14 2.00 26.0320 24.03201-Mar-13 2.50 25.0153 22.5153

29-Mar-12 1.50 23.5418 22.041811-Mar-11 2.00 23.4875 21.629424-Jul-09 2.00 17.1017 15.288619-Mar-08 1.50 18.1927 16.55791-Feb-07 1.50 20.8782 19.52547-Aug-06 1.00 16.4146 15.4147

Disclaimer pertaining to SIP Returns: Past performance may or may not be sustained in the future. Returns on SIP and Benchmark are annualised and cumulative investment return for cash flows resulting out of uniform and regular monthly subscriptions have been worked out on excel spreadsheet function known as XIRR. It is assumed that a SIP of Rs. 10,000/- each executed on 10th of every month for Growth Plan (Regular Plan) has been taken into consideration including the first installment. It may please be noted that load has not been taken into consideration. The amounts invested in SIP and the market values of such investments at respective periodic intervals thereof are simu-lated for illustrative purposes for understanding the concept of SIP. This illustration should not be construed as a promise, guarantee on or a forecast of any minimum returns. The Mutual Fund or the Investment Manager does not assure any safeguard of capital and the illustrated returns are not necessarily indicative of future results and may not necessarily provide a basis for comparison with other investments. SIP does not guarantee or assure any protection against losses in declining market conditions.

Disclaimer pertaining to Dividend History: Past performance may or may not be sustained in the future. Dividend distribution is subject to availability & adequacy of distributable surplus. The Mutual Fund is not assuring that it will make periodical dividend distributions, though it has every intention of doing so. After the payment of dividend, the per unit NAV falls to the extent of the dividend payout and distribution taxes, if any. Performance of dividend plan/option would be net of applicable statutory levy , if any. Face value of Rs.10. * NAV on the 1st transaction day after Record Date, which includes the mark to market impact also. The above table provides dividend details of Dividend Plan (Regular Plan).

General Disclaimer:Data as on 31st March 2019. Past Performance may or may not be sustained in future. Sector(s)/ Stock(s)/ Issuer(s) mentioned above are for the purpose of disclosure of the portfolio of the scheme(s) and should not be construed as a recommendation. The Fund manager(s) may or may not choose to hold the stock mentioned, from time to time. Investors are requested to consult their financial, tax and other advisors before taking any investment decision(s).

1.0

10.0

1.0

6.6

0.0

2.0

4.0

6.0

8.0

10.0

12.0

Mar 2005 Mar 2019

Reliance Multi Cap Fund

S&P BSE 500 (TRI)

Rs. 1 lac invested at the time of inception is worth Rs. 10 lac in the scheme compared to Rs. 6.6 lac in the Benchmark.

1.2 3.6 6.0 12.0 16.8

1.3 4.3 7.8

26.0

54.2

0.0

20.0

40.0

60.0

1 Year 3 Years 5 Years 10 Years Since Inception

SIP Performance

Total Amount Invested (Rs. Lakhs) Market Value (Rs. Lakhs)

0%10%20%30%40%50%

more than Rs. 27,944 crs Rs. 8,519 crs to Rs.

27,944 crs less than Rs. 8,519 crs

49%

29%

22%

Portfolio Market Capitalization

TRI

Reliance Multi Cap Fund

3

SCHEME PERFORMANCE SUMMARY

Reliance Multi Cap FundNAV as on Mar 29, 2019: Rs 99.6590

Particulars CAGR %

1 Year 3 Years 5 Years Since Inception

Reliance Multi Cap Fund 11.07 14.52 14.87 17.83

B: S&P BSE 500 TRI 9.64 15.97 14.52 14.40

AB: S&P BSE Sensex TRI 18.71 16.64 13.12 14.92

Value of Rs.10,000 Invested

Reliance Multi Cap Fund 11,110 15,006 19,991 99,659

B: S&P BSE 500 TRI 10,967 15,585 19,690 65,895

AB: S&P BSE Sensex TRI 11,877 15,857 18,518 70,169

Inception Date: Mar 28, 2005

Fund Manager: Sailesh Raj Bhan (Since Mar 2005)

Note: Different plans shall have a different expense structure. The performance details provided herein are of Growth Plan (Regular Plan).

As TRI data is not available since inception of the scheme, benchmark performance is calculated using composite CAGR of S&P BSE 500 PRI values from 28/03/2005 to 29/06/2007 and TRI values since 29/06/2007.

As TRI data is not available since inception of the scheme, benchmark performance is calculated using composite CAGR of S&P BSE Sensex PRI values from 28/03/2005 to 31/05/2007 and TRI values since 31/05/2007.

PERFORMANCE OF OTHER OPEN ENDED SCHEMES MANAGED BY THE SAME FUND MANAGER (as on 31st March 2019)

Fund Manager: Sailesh Raj Bhan

Scheme Name/sCAGR %

1 Year Return 3 Years Return 5 Years ReturnScheme Benchmark Scheme Benchmark Scheme Benchmark

Reliance Pharma Fund 13.48 10.10 4.97 -1.15 11.63 8.00Reliance Consumption Fund -1.18 3.65 7.50 13.83 9.77 14.09Reliance Large Cap Fund 14.23 13.86 16.92 16.21 16.82 13.55

Mr. Sailesh Raj Bhan has been managing Reliance Pharma Fund since Jun 2004.Mr. Sailesh Raj Bhan has been managing Reliance Consumption Fund since Sep 2004 & jointly with Ms. Jahnvee Shah since May 25, 2018.Mr. Sailesh Raj Bhan has been managing Reliance Large Cap Fund since Aug 2007

Note: a. Mr. Sailesh Raj Bhan manages 4 open-ended schemes of Reliance Mutual Fund .b. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund

manager has been provided herein.c. Period for which scheme’s performance has been provided is computed basis last day of the month-end preceding the date of advertisementd. Different plans shall have a different expense structure. The performance details provided herein are of Growth Plan (Regular Plan).

Note: Performance as on 31st March 2019

B: Benchmark, AB: Additional Benchmark, TRI: Total Return Index

Past performance may or may not be sustained in future and the same may not necessarily provide the basis for comparison with other investment. Performance of the schemes (wherever provided) are calculated basis CAGR for the past 1 year, 3 years, 5 years and since inception. Dividends (if any) are assumed to be reinvested at the prevailing NAV. In case, the start/end date of the concerned period is non-business day (NBD), the NAV of the previous date is considered for computation of returns. Schemes which have not completed one year, performance details for the same are not provided. Performance details of closed ended schemes are not provided since these are not comparable with other schemes. TRI - Total Returns Index refl ects the returns on the index arising from (a) constituent stock price movements and (b) dividend receipts from constituent index stocks, thereby showing a true picture of returns. In the perf ormance of other open ended schemes managed by the fund managers, the performance of the equity schemes is benchmarked to the Total Return variant of the Index.

PRODUCT LABELS

Name of Scheme This product is suitable for investors who are seeking*:

Reliance Large Cap Fund(Formerly, Reliance Top 200 Fund)(An open ended equity scheme predominantly investing in large cap stocks)

• Long term capital growth

• Investment predominantly into equity and equity related instru-ments of large cap companies

Reliance Consumption Fund(Formerly, Reliance Media & Entertainment Fund)(An open ended equity scheme following con-sumption theme)

• Long term capital growth

• Investment in equity, equity related securities of companies that are likely to benefit directly or indirectly from domestic consump-tion led demand

Reliance Pharma Fund(An open ended equity scheme investing in Pharma sector)

• Long term capital growth

• Investment in equity and equity related securities of pharma and other associated companies

*Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

Investors understand that their principalwill be at Moderately High risk

Investors understand that their principalwill be at High risk

Reliance Multi Cap Fund

4

SIP PERFORMANCE OF EQUITY SCHEMES (as on 31st March 2019)

Reliance Multi Cap FundPeriod Since Inception 15 Years 10 Years 5 Years 3 Years 1 Year

Total Amount Invested (Rs.) 1,680,000 - 1,200,000 600,000 360,000 120,000

Market Value (Rs.) 5,417,660 - 2,598,019 784,025 430,652 130,111

Scheme Return (%) 15.45 - 14.85 10.77 12.25 17.01

B: S&P BSE 500 TRI Return (%) N.A. - 12.67 11.85 11.86 11.44

AB: S&P BSE Sensex TRI Return (%) N.A. - 12.52 12.88 15.73 17.44

N.A: Since TRI data is not available prior to 29/06/2007 & 31/05/2007 for S&P BSE 500 & S&P BSE Sensex respectively, performance for such period is not provided.

Reliance Large Cap FundPeriod Since Inception 15 Years 10 Years 5 Years 3 Years 1 Year

Total Amount Invested (Rs.) 1,400,000 - 1,200,000 600,000 360,000 120,000

Market Value (Rs.) 3,355,334 - 2,572,405 831,673 441,981 130,506

Scheme Return (%) 14.20 - 14.67 13.18 14.09 17.69

B: S&P BSE 100 TRI Return (%) N.A. - 12.48 12.18 13.42 14.49

AB: S&P BSE Sensex TRI Return (%) N.A. - 12.52 12.88 15.73 17.44

N.A: Since TRI data is not available prior to 29/06/2007 & 31/05/2007 for S&P BSE 100 & S&P BSE Sensex respectively, performance for such period is not provided.

Reliance Consumption FundPeriod Since Inception 15 Years 10 Years 5 Years 3 Years 1 Year

Total Amount Invested (Rs.) 1,740,000 - 1,200,000 600,000 360,000 120,000

Market Value (Rs.) 4,041,815 - 2,064,120 682,953 374,425 123,126

Scheme Return (%) 10.89 - 10.52 5.19 2.62 5.17

B: Nifty India Consumption TRI Return (%) N.A. - 13.38 10.73 8.81 -1.13

AB: S&P BSE Sensex TRI Return (%) N.A. - 12.52 12.88 15.73 17.44

N.A: Since TRI data is not available prior to 14/02/2012 & 31/05/2007 for Nifty India Consumption Index & S&P BSE Sensex, performance for such period is not provided.

Reliance Pharma FundPeriod Since Inception 15 Years 10 Years 5 Years 3 Years 1 Year

Total Amount Invested (Rs.) 1,780,000 - 1,200,000 600,000 360,000 120,000

Market Value (Rs.) 7,618,175 - 2,488,883 689,832 393,060 123,400

Scheme Return (%) 17.82 - 14.05 5.59 5.92 5.62

B: S&P BSE HC TRI Return (%) N.A. - 10.85 0.12 -0.21 4.83

AB: S&P BSE Sensex TRI Return (%) N.A. - 12.52 12.88 15.73 17.44

N.A: Since TRI data is not available prior to 31/12/2007 & 31/05/2007 for S&P BSE Healthcare & S&P BSE Sensex, performance for such period is not provided.

Inception Dates: Reliance Multi Cap Fund - 28/03/2005, Reliance Large Cap Fund - 08/08/2007, Reliance Consumption Fund - 30/09/2004, Reliance Pharma Fund - 05/06/2004.

B: Benchmark, AB: Additional Benchmark, TRI: Total Return Index

TRI - Total Returns Index reflects the returns on the index arising from (a) constituent stock price movements and (b) dividend receipts from constituent index stocks, thereby showing a true picture of returns.

Disclaimer: Returns on SIP and Benchmark are annualised and cumulative investment return for cash flows resulting out of uniform and regular monthly subscriptions have been worked out on excel spreadsheet function known as XIRR. It is assumed that a SIP of Rs. 10,000/- each executed on 10th of every month for Growth Plan (Regular Plan) has been taken into consideration including the first in-stallment. It may please be noted that load has not been taken into consideration. The amounts invested in SIP and the market values of such investments at respective periodic intervals thereof are simulated for illustrative purposes for understanding the concept of SIP. This illustration should not be construed as a promise, guarantee on or a forecast of any minimum returns. The Mutual Fund or the Invest-ment Manager does not assure any safeguard of capital and the illustrated returns are not necessarily indicative of future results and may not necessarily provide a basis for comparison with other investments. SIP does not guarantee or assure any protection against losses in declining market conditions.

Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.